Daneng Li, MD, of City of Hope talks about research presented at the North American Neuroendocrine Tumor Society (NANETS) 2025 meeting.

Cancer surgery among patients older than 65 years is complex with high morbidity underscoring the need for specialized care at high-quality hospitals.

The researchers proposed adopting a standardized framework that would outline the core elements needed for informed decision-making across cancer types.

No differences seen among one-, two-, and three-year interval cancer predictions, age quartiles, or breast densities.

ESMO 2025 bladder cancer highlights include results from KEYNOTE-905/EV-303, RC48-C016, and IMvigor011 studies.

Alongside reducing body mass index, “physical activity may have systematic anticancer effect, such as improving insulin sensitivity, reducing hyperinsulinemia, lowering systemic inflammation, and ...

A phase 2 RCT evaluated progression of prostate-specific antigen and urinary symptoms in men with low-risk prostate cancer who were administered phytochemical-rich food and Lactobacillus probiotic ...

Rates for plans sold through federal Obamacare marketplaces will rise, on average, by 30% next year, according to a new analysis from the health research group KFF. States that run their own ...

The ESC has published a scientific statement regarding heart failure with preserved ejection fraction in patients with cancer and cancer survivors.

The phase 3 ALBAN trial tested atezolizumab plus BCG in BCG-naïve patients with high-risk, non-muscle-invasive bladder cancer (NMIBC).

(HealthDay News) — The US Food and Drug Administration approved belantamab mafodotin-blmf in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or ...

A cross-sectional study evaluated if the mode of sexual orientation and gender identification disclosure was associated with receiving clinical resources tailored to LGBTQ+ cancer survivors.